KBL Merger Corp. IV (KBLM)
|Net Income (ttm)||-2.84M|
|Trading Day||Nov 6, 2021|
|Day's Range||4.60 - 6.05|
|52-Week Range||4.60 - 11.50|
KBL Merger Corp. IV Announces Approval of Business Combination with 180 Life Sciences at the Special Meeting of Shareholders Held on November 5, 2020
NEW YORK, Nov. 06, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC) that previously announced an agreement to acquire ...
Last week saw continued momentum in special purpose acquisition company (SPAC) mergers, as KBL Merger (NASDAQ: KBLM), Acamar Partners Acquisition Corp. (NASDAQ: ACAM), Panacea Acquisition Corp...
NEW YORK, Oct. 23, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC) that previously announced an agreement to acquire ...
KBL Merger Corp. IV (NASDAQ: KBLM) on Friday announced its acquisition of a new cannabis biotech company CannBioRx Life Sciences Corp.
KBL Merger IV is a private equity firm specializing in acquisition, buyout, PIPES and secondaries investments. The firm seeks to invest in healthcare or the healthcare-related wellness industry. In healthcare services the firm seeks to invest in outpatient care, physician practices, behavioral health and payor services. In pharma services the firm seeks to invest in outsourced services, contract research and generics / OTC. In health IT the firm seeks to invest in EMR / HER, revnue cycle management, telemedicine and care management. In minimal ... [Read more...]
|IPO Date |
Jun 2, 2017
Marlene R. Krauss
|Stock Exchange |
|Ticker Symbol |